Summary

Persistence Market Research has recently published a comprehensive report on the global infant clinical nutrition market, providing an in-depth assessment of key market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.

Key Insights:

• Infant Clinical Nutrition Market Size (2024E): USD 27491.8 Mn
• Projected Market Value (2033F): USD 45733.7 Mn
• Global Market Growth Rate (CAGR 2024 to 2033): 5.8%

Scope of the Report: Infant Clinical Nutrition Market

Infant clinical nutrition plays a vital role in supporting the health and development of newborns and infants worldwide. This market encompasses a diverse range of nutritional products specifically designed for infants, including infant formula, baby food, and nutritional supplements. Key stakeholders in this market include manufacturers, healthcare providers, and regulatory bodies, each contributing to market growth and the establishment of regulatory frameworks.

Market Growth Drivers:

The global infant clinical nutrition market is driven by several key factors, such as increasing birth rates, growing awareness about the significance of early childhood nutrition, and advancements in nutritional science. There is a rising demand for specialized infant formulas tailored to address various health conditions like lactose intolerance, allergies, and complications arising from preterm birth, which further propels market expansion. Additionally, the escalating adoption of organic and natural infant food products among health-conscious parents significantly stimulates market growth.

Market Challenges:

Despite promising growth prospects, the infant clinical nutrition market encounters challenges related to stringent regulatory requirements, particularly concerning product safety, labeling, and advertising claims. Economic fluctuations, pricing pressures, and disruptions in the supply chain also impact market dynamics, posing challenges for market players striving for sustained profitability and expansion.

Market Opportunities:

The infant clinical nutrition market presents substantial growth opportunities driven by demographic trends, evolving dietary preferences, and ongoing advancements in nutritional research. Innovations in product formulations, such as hypoallergenic formulas and baby foods enriched with probiotics, cater to emerging consumer demands for healthier and functional infant nutrition options. Strategic collaborations among manufacturers, healthcare providers, and nutritionists are pivotal in developing evidence-based nutritional solutions and expanding market presence across diverse demographic segments.

Key Questions Addressed in the Report:

• What are the primary drivers fueling the growth of the global infant clinical nutrition market?
• Which product segments and nutritional formulations are witnessing increased adoption among parents and healthcare providers?
• How are regulatory developments and consumer preferences shaping the competitive landscape of the infant clinical nutrition market?
• Who are the key players contributing to the infant clinical nutrition market, and what strategies are they employing to maintain market leadership?
• What are the emerging trends and future prospects in the global infant clinical nutrition market?

Competitive Intelligence and Business Strategy:

Leading companies in the global infant clinical nutrition market, including Nestlé S.A., Abbott Laboratories, Danone S.A., Mead Johnson Nutrition Company, and Reckitt Benckiser Group plc, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest significantly in research and development to introduce new nutritional products tailored to specific health needs and consumer preferences. Collaborations with pediatricians, hospitals, and retail channels enhance product distribution and market penetration, ensuring comprehensive infant nutrition solutions on a global scale.

Key Companies Profiled:

• Abbott Laboratories
• Baxter International Inc.
• Nestlé S.A.
• Danone
• Meiji Holdings Co., Ltd.,
• Fresenius SE & Co. KGaA
• Reckitt Benckiser Group Plc
• Perrigo Co. Plc
• Ingredion Inc.
• Solace Nutrition

Infant Clinical Nutrition Industry Research by Category

By Product Type:
• Milk-Based
• Soy-Based
• Organic
• Probiotic/Prebiotic

By Route of Administration:
• Oral administration
• Enteral administration
• Intravenous administration

By Region:
• North America
• Latin America
• Europe
• South Asia & Pacific
• East Asia
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.1.1. Increasing Birth Rate with the Growing Number of Premature Births Creates Needs for Infant Nutrition Supplements
3.1.2. Advancements in the Nutritional Modifications in the Infant Food Products to Boost the Market Growth
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
4.3. Strategic Promotional Strategies
5. Global Infant Clinical Nutrition Market - Pricing Analysis
5.1. Regional Pricing Trend Analysis, 2019-2023
5.2. Global Average Pricing Analysis Benchmark
6. Global Infant Clinical Nutrition Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033
6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Market Background
7.1. Macro-Economic Factors
7.1.1. Global GDP Growth Outlook
7.1.2. Global Food & Beverage industry Overview
7.1.3. Global GDP and Infrastructure Investment
7.1.4. International Trade
7.1.5. Global Industry Outlook
7.2. Forecast Factors - Relevance & Impact
7.2.1. Top Companies Historical Growth
7.2.2. GDP Growth forecast
7.2.3. Manufacturing Industry forecast
7.2.4. Global Urbanization Growth Outlook
7.2.5. Business Climate
7.3. Global Food and Beverage Industry Overview
7.4. Global Dairy Industry Overview
7.5. Supply Chain & Value-Chain Analysis
7.5.1. Raw Material Suppliers
7.5.2. Product Manufacturers
7.5.3. Distribution Channel Industries
7.6. Policy Developments and Regulatory Scenario
7.6.1. The United States Food and Drug Administration (FDA)
7.6.2. Canadian Food Inspection Agency
7.6.3. European Food Safety Authority (EFSA)
7.6.4. The Food Safety and Standards Authority of India (FSSAI)
7.6.5. Ministry of Health, Labor and Welfare. (MHLW), Japan
7.6.6. National Health Commission (NHC), China
7.6.7. Food Standards Australia New Zealand (FSANZ)
7.7. Market Dynamics
7.7.1. Drivers
7.7.2. Restraints
7.7.3. Opportunity Analysis
7.8. Global Supply Demand Analysis
8. Global Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033, by Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) By Product Type, 2019-2023
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2024-2033
8.3.1. Milk-Based
8.3.2. Soy-Based
8.3.3. Organic
8.3.4. Probiotic/Prebiotic
8.4. Market Attractiveness Analysis By Product Type
9. Global Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033, By Route of Administration
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Volume Analysis By Route of Administration, 2019-2023
9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Route of Administration, 2024-2033
9.3.1. Oral administration
9.3.2. Enteral administration
9.3.3. Intravenous administration
9.4. Market Attractiveness Analysis By Route of Administration
10. Global Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2019-2023
10.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2024-2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. South Asia and Pacific
10.3.5. East Asia
10.3.6. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
11.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
11.4.1. By Country
11.4.1.1. U.S.
11.4.1.2. Canada
11.4.2. By Product Type
11.4.3. By Route of Administration
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Product Type
11.5.3. By Route of Administration
11.6. Market Trends
11.7. Key Market Participants - Intensity Mapping
11.8. Drivers and Restraints - Impact Analysis
12. Latin America Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
12.4.1. By Country
12.4.1.1. Brazil
12.4.1.2. Mexico
12.4.1.3. Argentina
12.4.1.4. Rest of Latin America
12.4.2. By Product Type
12.4.3. By Route of Administration
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By Route of Administration
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis
13. Europe Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
13.4.1. By Country
13.4.1.1. Germany
13.4.1.2. Italy
13.4.1.3. France
13.4.1.4. U.K.
13.4.1.5. Spain
13.4.1.6. BENELUX
13.4.1.7. Russia
13.4.1.8. Poland
13.4.1.9. Rest of Europe
13.4.2. By Product Type
13.4.3. By Route of Administration
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By Route of Administration
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
14. South Asia and Pacific Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
14.4.1. By Country
14.4.1.1. India
14.4.1.2. ASEAN
14.4.1.3. Oceania (Australia & New Zealand)
14.4.1.4. Rest of South Asia & Pacific
14.4.2. By Product Type
14.4.3. By Route of Administration
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By Route of Administration
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. East Asia Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.2. By Product Type
15.4.3. By Route of Administration
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By Route of Administration
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. Middle East and Africa Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. Turkey
16.4.1.3. Northern Africa
16.4.1.4. South Africa
16.4.1.5. Rest of Middle East and Africa
16.4.2. By Product Type
16.4.3. By Route of Administration
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By Route of Administration
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. Country Wise Infant Clinical Nutrition Market Analysis, 2024
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. U.S. Infant Clinical Nutrition Market Analysis
17.2.1. By Product Type
17.2.2. By Route of Administration
17.3. Canada Infant Clinical Nutrition Market Analysis
17.3.1. By Product Type
17.3.2. By Route of Administration
17.4. Mexico Infant Clinical Nutrition Market Analysis
17.4.1. By Product Type
17.4.2. By Route of Administration
17.5. Brazil Infant Clinical Nutrition Market Analysis
17.5.1. By Product Type
17.5.2. By Route of Administration
17.6. Argentina Infant Clinical Nutrition Market Analysis
17.6.1. By Product Type
17.6.2. By Route of Administration
17.7. Germany Infant Clinical Nutrition Market Analysis
17.7.1. By Product Type
17.7.2. By Route of Administration
17.8. Italy Infant Clinical Nutrition Market Analysis
17.8.1. By Product Type
17.8.2. By Route of Administration
17.9. France Infant Clinical Nutrition Market Analysis
17.9.1. By Product Type
17.9.2. By Route of Administration
17.10. U.K. Infant Clinical Nutrition Market Analysis
17.10.1. By Product Type
17.10.2. By Route of Administration
17.11. Spain Infant Clinical Nutrition Market Analysis
17.11.1. By Product Type
17.11.2. By Route of Administration
17.12. Poland Infant Clinical Nutrition Market Analysis
17.12.1. By Product Type
17.12.2. By Route of Administration
17.13. Russia Infant Clinical Nutrition Market Analysis
17.13.1. By Product Type
17.13.2. By Route of Administration
17.14. China Infant Clinical Nutrition Market Analysis
17.14.1. By Product Type
17.14.2. By Route of Administration
17.15. Japan Infant Clinical Nutrition Market Analysis
17.15.1. By Product Type
17.15.2. By Route of Administration
17.16. S. Korea Infant Clinical Nutrition Market Analysis
17.16.1. By Product Type
17.16.2. By Route of Administration
17.17. India Infant Clinical Nutrition Market Analysis
17.17.1. By Product Type
17.17.2. By Route of Administration
17.18. Oceania (Australia and New Zealand) Infant Clinical Nutrition Market Analysis
17.18.1. By Product Type
17.18.2. By Route of Administration
17.19. Turkey Infant Clinical Nutrition Market Analysis
17.19.1. By Product Type
17.19.2. By Route of Administration
17.20. South Africa Infant Clinical Nutrition Market Analysis
17.20.1. By Product Type
17.20.2. By Route of Administration
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies (Infant Clinical Nutrition)
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. Abbott Laboratories
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Profitability by Market Segments (Product/Channel/Region)
19.3.1.4. Sales Footprint
19.3.1.5. Strategy Overview
19.3.2. Baxter International
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Profitability by Market Segments (Product/Channel/Region)
19.3.2.4. Sales Footprint
19.3.2.5. Strategy Overview
19.3.3. Nestle S.A.
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Profitability by Market Segments (Product/Channel/Region)
19.3.3.4. Sales Footprint
19.3.3.5. Strategy Overview
19.3.4. Danone
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Profitability by Market Segments (Product/Channel/Region)
19.3.4.4. Sales Footprint
19.3.4.5. Strategy Overview
19.3.5. Meiji Holdings Co., Ltd.
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Profitability by Market Segments (Product/Channel/Region)
19.3.5.4. Sales Footprint
19.3.5.5. Strategy Overview
19.3.6. Fresenius SE & Co. KGaA
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Profitability by Market Segments (Product/Channel/Region)
19.3.6.4. Sales Footprint
19.3.6.5. Strategy Overview
19.3.7. Reckitt Benckiser Group Plc
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Profitability by Market Segments (Product/Channel/Region)
19.3.7.4. Sales Footprint
19.3.7.5. Strategy Overview
19.3.8. Perrigo Co. Plc
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Profitability by Market Segments (Product/Channel/Region)
19.3.8.4. Sales Footprint
19.3.8.5. Strategy Overview
19.3.9. Ingredion Inc.
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Profitability by Market Segments (Product/Channel/Region)
19.3.9.4. Sales Footprint
19.3.9.5. Strategy Overview
19.3.10. Solace Nutrition
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Profitability by Market Segments (Product/Channel/Region)
19.3.10.4. Sales Footprint
19.3.10.5. Strategy Overview
19.3.11. Others ( on Additional Request)
19.3.11.1. Overview
19.3.11.2. Product Portfolio
19.3.11.3. Profitability by Market Segments (Product/Channel/Region)
19.3.11.4. Sales Footprint
19.3.11.5. Strategy Overview
20. Assumptions and Acronyms Used
21. Research Methodology